Specializing in robotic-assisted surgery, this company develops the Senhance Surgical System, a platform designed to enhance precision in minimally invasive procedures. With a focus on digital laparoscopy, it targets hospitals and surgical centers seeking to improve patient outcomes through advanced technology. Investors monitor its progress due to its niche position in the growing surgical robotics market.
1 member of Congress has disclosed 2 trades in Asensus Surgical, Inc. (ASXC), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-12-20 | Kevin Hern | sell | $15K – $50K |
| 2021-06-25 | Kevin Hern | buy | $100K – $250K |